A Randomized Phase II Study of Cilengitide (EMD 121974) in Patients with Metastatic Melanoma

Cilengitide (EMD121974) is a selective inhibitor of integrins α(v)β(3) and α(v)β(5). The α(v)β(3) promotes the proliferation of tumor-associated endothelial cells and potentially the survival of melanoma cells. We conducted a randomized phase II trial in patients with metastatic melanoma to evaluate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Kevin B., Prieto, Victor, Joseph, Richard W., Diwan, Abdul H., Gallick, Gary E., Papadopoulos, Nicholas E., Bedikian, Agop Y., Camacho, Luis H., Hwu, Patrick, Ng, Chaan S., Wei, Wei, Johnson, Marcella M., Wittemer, Sabine M., Vardeleon, Anna, Reckeweg, Aaron, Colevas, A. Dimitrios
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880198/
https://ncbi.nlm.nih.gov/pubmed/22668797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0b013e32835312e4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados